Alkermes (ALKS) FCF Margin Growth (3y) (2013 - 2026)
Alkermes (ALKS) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.38 Bn | 43.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.73 Bn | 40.08 Bn | 2.15 Bn | 213.00 |
| 3 | Zoetis | 32.43 Bn | 30.76 Bn | 1.05 Bn | 2,102.00 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 180.00 |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 1,592.00 |
| 6 | Viatris | 18.94 Bn | 18.05 Bn | 1.46 Bn | -291.00 |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn | -2,476.00 |
| 8 | Elanco Animal Health | 12.01 Bn | 11.48 Bn | 798.00 Mn | 1,604.00 |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.10 Bn | 7.44 Bn | 397.90 Mn | -574.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -574.00 |
| Mar 31, 2026 | -3,343.00 |
| Dec 31, 2025 | 4,718.00 |
| Sep 30, 2025 | 32,918.00 |
| Jun 30, 2025 | 41,849.00 |
| Mar 31, 2025 | 2,395.00 |
| Dec 31, 2024 | 3,512.00 |
| Sep 30, 2024 | -711.00 |
| Jun 30, 2024 | 2,608.00 |
| Mar 31, 2024 | 2,478.00 |
| Dec 31, 2023 | 179.00 |
| Sep 30, 2023 | 208.00 |
| Jun 30, 2023 | 3,943.00 |
| Mar 31, 2023 | 1,461.00 |
| Dec 31, 2022 | -20,495.00 |
| Sep 30, 2022 | -31,230.00 |
| Jun 30, 2022 | -36,941.00 |
| Mar 31, 2022 | 563.00 |
| Dec 31, 2021 | -8,198.00 |
| Sep 30, 2021 | 1,965.00 |